Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
Fierce Pharma
Sun, 03/10/24 - 08:40 pm
Merck KGaA
earnings
CDMOs
Legal Challenges To IRA Drug Price Negotiations Face Skeptical Judges
Forbes
Sun, 03/10/24 - 08:34 pm
drug pricing
Inflation Reduction Act
legal
Novartis' BTK inhibitor beats placebo in dermatology trial, lining up another potential indication
Fierce Biotech
Sun, 03/10/24 - 08:29 pm
Novartis
dermatology
Btk inhibitors
remibrutinib
hidradenitis suppurativa
clinical trials
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity
Drugs.com
Sun, 03/10/24 - 08:28 pm
Regor Therapeutics
clinical trials
GLP-1 agonist
RGT-075
obesity
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Fresenius Kabi
FDA
biosimilars
Actemra
Tyenne
Genentech
UCB launches DTC Bimzelx ad blitz at the Oscars
Medical Marketing and Media
Sun, 03/10/24 - 08:23 pm
UCB Pharma
DTC advertising
Oscars
psoriasis
March 8 2024 - Lilly’s donanemab hit with surprise delay, set to face FDA adcomm
Fri, 03/8/24 - 11:59 am
Lilly’s Donanemab Hit with Surprise Delay, Set to Face FDA Adcomm
BioSpace
Fri, 03/8/24 - 11:55 am
Eli Lilly
FDA
Alzheimer's disease
donanemab
Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
Fierce Pharma
Fri, 03/8/24 - 11:54 am
Bristol Myers Squibb
Opdivo
FDA
bladder cancer
After trial failure, will Amylyx pull ALS drug Relyvrio off the market?
Fierce Pharma
Fri, 03/8/24 - 11:33 am
Amylyx
ALS
Relyvrio
Food allergy biotech DBV is running out of cash, with phase 3 trials underway
Fierce Biotech
Fri, 03/8/24 - 11:32 am
DBV Technologies
food allergies
earnings
clinical trials
peanut allergy
Roche to take on Abbott, Dexcom with its first CGM
Medtech Dive
Fri, 03/8/24 - 11:13 am
Medtech
Roche
CGMs
diabetes
Abbott Labs
DexCom
Accu-Chek Smartguide
Novo Nordisk confident of amycretin obesity drug launch this decade
Reuters
Fri, 03/8/24 - 11:09 am
Novo Nordisk
amycretin
weight loss
obesity
AbbVie ends stay with the ADAM family, dropping MacroGenics-partnered ADC in light of early data
Fierce Biotech
Fri, 03/8/24 - 11:07 am
AbbVie
IMGC936
ADAM9
solid tumors
Macrogenics
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
Stat
Fri, 03/8/24 - 11:05 am
President Biden
Big Pharma
State of the Union
drug pricing
MindMed gets FDA breakthrough tag for LSD in anxiety
Pharmaphorum
Fri, 03/8/24 - 11:03 am
MindMed
FDA
LSD
anxiety
MM120
Into the unknown: Tarsus’ CEO on its launch strategies in a new disease category
Pharma Voice
Fri, 03/8/24 - 11:01 am
Tarsus Pharmaceuticals
Demodex blepharitis
Xdemvy
Launches and prices of Novo Nordisk's weight-loss drug Wegovy
Reuters
Fri, 03/8/24 - 10:59 am
Novo Nordisk
drug launches
Wegovy
drug pricing
weight loss
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
GSK Advances Blenrep’s Potential Comeback with Second Phase III Win
BioSpace
Thu, 03/7/24 - 05:32 pm
GSK
Blenrep
antibody-drug conjugate
clinial trials
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »